Skip to content

CARPENTIER-EDWARDS PERIMOUNT THEON PERICARDIALBIOPROSTHESIS - MITRAL 6900PTFX (REF 6900PTFX27)Recalls & reported problems

Edwards Lifesciences LLC · CARPENTIER-EDWARDS PERIMOUNT THEON PERICARDIAL BIOPROSTHESIS - MITRAL · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Edwards Lifesciences Perimount Theon mitral heart valve is a tissue-based replacement valve implanted surgically. The 59 reports mostly describe valves implanted for years that later narrowed (stenosis), calcified, or leaked, leading to breathing trouble, fatigue and heart failure, and often needing a second valve placed inside or replacing it. No deaths were reported, and 59 injuries were. There are no recalls naming this device. Reports dropped sharply in the last 12 months, from 19 to 1.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
59
Deaths reported
0
Injuries reported
59
Recalls naming it
0

Summary

The FDA's MAUDE database contains 59 adverse event reports that list this exact device (DI 00690103163599), received between Feb 5, 2021 and Mar 10, 2026 — classified as 59 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (23 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 2 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 3 reportsJun 2024: 5 reportsJul 2024: 1 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 2 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 2 reportsMay 2025: 3 reportsJun 2025: 2 reportsJul 2025: 5 reportsAug 2025: 1 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520265
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information23
  • Gradient Increase17
  • Device Stenosis16
  • Fluid/Blood Leak13
  • Calcified5
  • Degraded5
  • Difficult to Open or Close4
  • Intravalvular regurgitation4

Patient problems

  • Insufficient Information34
  • Dyspnea19
  • Heart Failure/Congestive Heart Failure13
  • Fatigue2
  • Cardiogenic Shock1
  • Chest Pain1
  • Endocarditis1
  • Mitral Valve Insufficiency/ Regurgitation1

Recent adverse event reports

The 25 most recent of 59 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 10, 2026Calcified

    IT WAS LEARNED THROUGH MEDICAL RECORDS THAT A 27MM 6900PTFX MITRAL VALVE WAS EXPLANTED AFTER AN IMPLANT DURATION OF 7 YEARS, 8 MONTHS DUE TO CALCIFICATION, SEVERE STENOSIS, MODERATE REGURGITATION. THE EXPLANTED DEVICE WAS REPLACED WITH A 31MM NON-EDWARDS' VALVE. PER MEDICAL RECORDS, THE PATIENT PRESENTED WITH HEART FAILURE AND CARDIOGENIC SHOCK AND UNDERWENT REDO MVR AND REDO AVR WITH AORTIC ROOT REPLACEMENT. INTRAOPERATIVE INSPECTION OF THE MITRAL 6900TFX VALVE REVEALED SOME CALCIUM AND STUCK LEAFLETS, THE VALVE AND PREVIOUSLY PRESERVED CHORDAE WERE RESECTED. A NON-EDWARDS MOSAIC VALVE WAS IMPLANTED IN THE MITRAL POSITION. THE 23MM 3000TFX WAS EXCISED, GIVEN BSA, AGE, AND SIZE OF THE VALVE, KONNO-RASTAN REPAIR WAS NECESSARY. LARGE ANTERIOR AORTOVENTRICULOTOMY WAS FASHIONED UNDER THE PV AND SEPTAL MYOMECTOMY PERFORMED. ONCE THE NEO-LVOT WAS ESTABLISHED A 23MM AVC WAS IMPLANTED. POST BYPASS TEE SHOWED AORTIC GRADIENT 11MMHG AND PRESERVED BIVENTRICULAR FUNCTION. THE PATIENT WAS TRANSPORTED TO THE (B)(6).

    Patient problems: Cardiogenic Shock

    MAUDE report 24564349 ↗
  • InjurySep 3, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 9 YEARS, 2 MONTHS DUE TO MITRAL STENOSIS. THE PATIENT PRESENTED WITH WORSENING SHORTNESS OF BREATH AND FATIGUE. THE TMVR WAS SUCCESSFULLY PERFORMED WITH A 26MM 9750TFX VALVE WITHOUT PATIENT COMPLICATION.

    Patient problems: Dyspnea

    MAUDE report 22955816 ↗
  • InjuryAug 19, 2025Intravalvular regurgitation; Intravalvular regurgitation

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 7 YEARS, 10 MONTHS DUE TO REGURGITATION. THE PATIENT PRESENTED WITH SHORTNESS OF BREATH AND DYSPNEA ON EXERTION. THE TMVR WAS SUCCESSFULLY PERFORMED WITH A 29MM 9755RSL VALVE. THE PATIENT WAS DISCHARGED POST-PROCEDURE.

    Patient problems: Dyspnea

    MAUDE report 22846404 ↗
  • InjuryJul 16, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 6 YEARS, 11 MONTHS DUE TO SEVERE STENOSIS. THE PATIENT PRESENTED WITH HEART FAILURE AND SOB. THE PROCEDURE WAS PERFORMED WITH A 26MM 9755RSL TRANSCATHETER VALVE.

    Patient problems: Dyspnea; Heart Failure/Congestive Heart Failure

    MAUDE report 22522122 ↗
  • InjuryJul 10, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A 6900PTFX 27MM MITRAL VALVE WAS DISABLED VIA A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 6 YEARS, 11 MONTHS DUE TO SEVERE STENOSIS. A 9600TFX 29MM TRANSCATHETER VALVE WAS IMPLANTED.

    Patient problems: Insufficient Information

    MAUDE report 22469578 ↗
  • InjuryJul 7, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF EIGHT (8) YEARS AND TEN (10) MONTHS DUE TO STENOSIS. THE PATIENT PRESENTED WITH DYSPNEA. THE PROCEDURE WAS PERFORMED WITH A 26MM 9755RSL TRANSCATHETER VALVE. THE PATIENT EXPIRED DUE TO TAMPONADE AND CARDIAC PERFORATION.

    Patient problems: Dyspnea

    MAUDE report 22423344 ↗
  • InjuryJul 7, 2025Device Stenosis; Device Stenosis

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY AND INVESTIGATION THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT REDO MVR AFTER AN IMPLANT DURATION OF 9 YEARS, 6 MONTHS DUE TO STENOSIS. PATIENT PRESENTED WITH HEART FAILURE. THE EXPLANTED VALVE WAS REPLACED WITH A 27MM 11400M MITRIS RESILIA VALVE. PATIENT WAS STABLE AND WAS DISCHARGED ON POD#13. THIS IS A 72-YEAR-OLD FEMALE PATIENT. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Heart Failure/Congestive Heart Failure

    MAUDE report 22410667 ↗
  • InjuryJul 3, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE WAS EXPLANTED AFTER AN IMPLANT DURATION OF 7 YEARS, 9 MONTHS DUE TO UNKNOWN REASONS. THE EXPLANTED VALVE WAS REPLACED WITH A 29MM 11400M VALVE. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Insufficient Information

    MAUDE report 22401374 ↗
  • InjuryJun 21, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A 27MM 6900PTFX MITRAL VALVE IN MITRAL POSITION WAS DISABLED VIA VALVE IN VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 8 YEARS, 9 MONTHS DUE TO STENOSIS. TMVR WAS COMPLETED WITH A 26MM 9755RSL TRANSCATHETER VALVE WITH GREAT OUTCOME.

    Patient problems: Insufficient Information

    MAUDE report 22303934 ↗
  • InjuryJun 11, 2025Calcified; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Calcified; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY AND INVESTIGATION THAT A 27MM 6900PTFX MITRAL VALVE WAS EXPLANTED AFTER AN IMPLANT DURATION OF 8 YEARS, 2 MONTHS DUE TO CUTIBACTERIUM MODESTUM ENDOCARDITIS. THE EXPLANTED DEVICE WAS REPLACED WITH A 27MM 11400M MITRIS RESILIA MITRAL VALVE. PER PATHOLOGY REPORT, THE EXPLANTED DEVICE TESTED POSITIVE FOR GRAM-POSITIVE COCCI AND CUTIBACTERIUM MODESTUMI. THERE IS ALSO BACKGROUND OF FIBROSIS AND LEAFLETS WERE IRREGULAR, NODULAR, WITH FOCAL CALCIFICATION CONSISTENT WITH MITRAL REGURGITATION.

    Patient problems: Dyspnea; Insufficient Information

    MAUDE report 22188814 ↗
  • InjuryMay 28, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY THAT A 27MM 6900PTFX VALVE, IMPLANTED IN TRICUSPID POSITION, WAS EXPLANTED AFTER AN IMPLANT DURATION OF 4 YEARS AND 11 MONTHS DUE TO UNKNOWN REASON. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Insufficient Information

    MAUDE report 22098297 ↗
  • InjuryMay 19, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 7300TFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF EIGHT (8) YEARS AND EIGHT (8) MONTHS DUE TO UNKNOWN REASON. THE PROCEDURE WAS PERFORMED WITH A 29MM 9755RSL TRANSCATHETER VALVE.

    Patient problems: Insufficient Information

    MAUDE report 22048945 ↗
  • InjuryMay 4, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 8 YEARS, 2 MONTHS DUE TO UNKNOWN REASONS. THE PROCEDURE WAS PERFORMED WITH A 29MM 9600TFX TRANSCATHETER VALVE. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Insufficient Information

    MAUDE report 21955957 ↗
  • InjuryApr 28, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A 27MM 6900PTFX MITRAL VALVE IN MITRAL POSITION WAS DISABLED VIA VALVE IN VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 9 YEARS, 1 MONTH DUE TO STENOSIS. THE PATIENT PRESENTED WITH HEART FAILURE AND SHORTNESS OF BREATH. TMVR WAS COMPLETED WITH A 26MM 9755RSL TRANSCATHETER VALVE AND PATIENT WAS IN STABLE CONDITION POST-OPERATIVE.

    Patient problems: Dyspnea; Heart Failure/Congestive Heart Failure

    MAUDE report 21918071 ↗
  • InjuryApr 21, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY THAT A 27MM 6900PTFX MITRAL VALVE IN MITRAL POSITION WAS DISABLED VIA VALVE IN VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 6 YEARS, 2 MONTHS DUE TO UNKNOWN REASONS. TMVR WAS COMPLETED WITH A 26MM 9755RSL TRANSCATHETER VALVE AND PATIENT WAS IN RECOVERY POST-PROCEDURE. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL "CUSTOMER COMPLAINT". THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Insufficient Information

    MAUDE report 21872875 ↗
  • InjuryMar 28, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM MITRAL VALVE HAS BEEN PLACED UNDER EVALUATION FOR A VALVE-IN-VALVE PROCEDURE AFTER AN UNKNOWN IMPLANT DURATION DUE TO STENOSIS.

    Patient problems: Insufficient Information

    MAUDE report 21725178 ↗
  • InjuryMar 7, 2025Fluid/Blood Leak; Intravalvular regurgitation; Fluid/Blood Leak; Intravalvular regurgitation

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX PERICARDIAL MITRAL VALVE WAS PLACED UNDER EVALUATION FOR VALVE-IN-VALVE INTERVENTION AFTER AN IMPLANT DURATION OF ONE (1) YEAR, 11 MONTHS DUE TO MITRAL REGURGITATION. THE PATIENT INITIALLY PRESENTED WITH CHF.

    Patient problems: Heart Failure/Congestive Heart Failure

    MAUDE report 21554391 ↗
  • InjuryJan 30, 2025Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 9 YEARS DUE TO SEVERE STENOSIS. THE TMVR WAS PERFORMED WITH A 26MM 9755RSL TRANSCATHETER VALVE.

    Patient problems: Insufficient Information

    MAUDE report 21276657 ↗
  • InjuryNov 21, 2024Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27 MM 6900 PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF OVER 8 YEARS DUE TO STENOSIS. THE PROCEDURE WAS PERFORMED WITH A 29 MM 9755RSL TRANSCATHETER VALVE.

    Patient problems: Insufficient Information

    MAUDE report 20748152 ↗
  • InjuryNov 18, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS LEARNED VIA THE PATIENT REGISTRY THAT A PATIENT WITH A 27MM 6900PTFX PERICARDIAL MITRAL VALVE UNDERWENT VALVE-IN-VALVE INTERVENTION AFTER AN IMPLANT DURATION OF EIGHT (8) YEARS, FOUR (4) MONTHS DUE TO UNKNOWN REASONS. THE TMVR PROCEDURE WAS PERFORMED WITH A 26MM 9755RSL TRANSCATHETER VALVE. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Insufficient Information

    MAUDE report 20707450 ↗
  • InjuryAug 26, 2024Patient Device Interaction Problem; Patient Device Interaction Problem

    IT WAS REPORTED THAT A 27MM 6900PTFX VALVE IN THE MITRAL POSITION UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AND IMPLANT DURATION OF 8 YEARS, 5 MONTHS DUE TO THROMBUS AND/OR PANNUS CAUSING MODERATE STENOSIS. THE TMVR WAS PERFORMED WITH A 29MM 9755RSL TRANSCATHETER VALVE. PER MEDICAL RECORDS, TEE ON (B)(6) 2023 NOTED TO HAVE LEAFLET THROMBOSIS AND WAS STARTED ON COUMADIN. THEN, TEE ((B)(6)2024) SHOWED MODERATE-SEVERE BIOPROSTHETIC VALVE STENOSIS SECONDARY TO THROMBUS/PANNUS FORMATION. THE PATIENT PRESENTED WITH ACUTE DIASTOLIC HEART FAILURE AND CARDIOGENIC SHOCK. THE PATIENT IS A 59 Y.O. FEMALE WITH HISTORY OF MVR(2016), SEVERE TR, HEART FAILURE, BIVENTRICULAR FAILURE, NICM AND HFREF (EF 40%), COPD, CKD STAGE 3, HTN, HLD, NSVT S/P ICD AND AF ON WARFARIN, CHRONIC THROMBOCYTOPENIA

    Patient problems: Heart Failure/Congestive Heart Failure; Thrombosis/Thrombus

    MAUDE report 20071178 ↗
  • InjuryJul 11, 2024Insufficient Device Problem Information; Device Stenosis; Insufficient Device Problem Information; Device Stenosis

    IT WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY THAT A PATIENT WITH A 27MM 6900PTFX MITRAL VALVE UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF 4 YEARS, 2 MONTHS DUE TO UNKNOWN REASONS. THE PROCEDURE WAS PERFORMED WITH A 26MM 9750TFX TRANSCATHETER VALVE. EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL 'CUSTOMER COMPLAINT'. THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE.

    Patient problems: Chest Pain; Dyspnea; Fatigue; Insufficient Information; Swelling/ Edema

    MAUDE report 19726912 ↗
  • InjuryJun 28, 2024Device Stenosis; Device Stenosis

    IT WAS LEARNED VIA THE PATIENT REGISTRY THAT A PATIENT WITH A 27MM 6900PTFX PERICARDIAL MITRAL VALVE UNDERWENT VALVE-IN-VALVE INTERVENTION AFTER AN IMPLANT DURATION OF EIGHT (8) YEARS, 10 MONTHS DUE TO MITRAL STENOSIS. THE PATIENT INITIALLY PRESENTED WITH SHORTNESS OF BREATH. THE TMVR PROCEDURE WAS PERFORMED WITH A 9755RSL TRANSCATHETER VALVE. THE PATIENT WAS STABLE POST PROCEDURE AND THEN DISCHARGED ON POD #1.

    Patient problems: Dyspnea

    MAUDE report 19634914 ↗
  • InjuryJun 27, 2024Device Stenosis; Device Stenosis

    IT WAS REPORTED THAT A PATIENT WITH A 27MM 6900PTFX VALVE IN THE AORTIC POSITION UNDERWENT A VALVE-IN-VALVE PROCEDURE AFTER AN IMPLANT DURATION OF SEVEN (7) YEARS AND TEN (10) MONTHS DUE TO STENOSIS. A TAVR PROCEDURE WAS PERFORMED WITH A 29MM 9755RSL TRANSCATHETER VALVE. THE PATIENT PRESENTED TO THE HOSPITAL FOR DYSPNEA. THE PATIENT WAS STABLE POST-PROCEDURE AND DISCHARGED ON POD# 1.

    Patient problems: Dyspnea; Insufficient Information

    MAUDE report 19630078 ↗
  • InjuryJun 11, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT PATIENT WITH A 27MM 6900PTFX MITRAL VALVE, HAS BEEN PLACED UNDER EVALUATION FOR A RE-INTERVENTION AFTER IMPLANT DURATION OF SEVEN (7) YEARS, FOUR (4) MONTHS DUE TO UNKNOWN REASON.

    Patient problems: Insufficient Information

    MAUDE report 19510402 ↗

Other replacement Heart-valve devices

All replacement Heart-valve devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page